Details for 2020186993

Up to date per 01.04.2026

Actions

Title / Product Name

BISPEZIFISCHE ANTIGENBINDENDE MOLEKÜLE ZUR BINDUNG VON CD3 UND CD20 SOWIE VERWENDUNGEN DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020186993

EP Publication Number

3778641

E-Number

1629555

Language

PCT Number

Publication Date

17.02.2021 A

08.11.2023 B1

Registration Date

08.11.2023

AT Publication Date

15.11.2023

Application Date

19.09.2013

Registration Number

Priorities

21.09.2012

201261704029 P

17.01.2013

201361753461 P

11.02.2013

201361763110 P

24.05.2013

201361827098 P

IPC

C07K 16/28 20060101AFI20230630BHEP

Maximum Duration of Protection

19.09.2033

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

SMITH, Eric310 Lexington Avenue Apt. 4E New York, NY 10016US

PAPADOPOULOS, Nicholas J59 Heritage Lane Lagrangeville, NY 12540US

Information about Fees